CG Oncology Inc. Common s...

22.28
0.76 (3.53%)
At close: Apr 25, 2025, 3:59 PM
24.04
7.90%
After-hours: Apr 25, 2025, 05:56 PM EDT

CG Oncology Common stock Revenue

CG Oncology Common stock reported an annual revenue of $1.14M, reflecting a 458.33% growth. For the quarter ending December 31, 2024, CG Oncology Common stock generated $456K in revenue.
Revenue (ttm)
$1.14M
Revenue Growth
458.33%
Price / Sales Ratio
1573.67
Revenue / Employee
$10.08K
Employees
113
Market Cap
1.7B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 1.14M +458.33%
Dec 31, 2023 204K +6.81%
Dec 31, 2022 191K -98.16%
Dec 31, 2021 10.36M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.